MedCity Influencers

Pharma consumer advertising: What’s the real cost?

I find it interesting that I can't get a $0.10 pen from the drug companies any longer, but our patients can get billions of dollars in advertising given to them "free" without any concern about what this is costing our health care system.

It seems the FDA is looking for input on how drug companies explain the side effects of their drugs in direct-to-consumer advertising.

But the pharmaceutical industry is requesting that only “reasonable consumers” need to be addressed about those side effects. Anyone that doesn’t act “reasonably,” well, so sorry.

presented by

Seriously?

About the only reasonable thing that can be said about direct-to-consumer advertising are three things:

  1. They are horribly expensive, with the US shunting over $2 billion dollars annually per pharmaceutical company to the advertising industry.
  2. It should also be noted that the FDA has a huge conflict of interest with the pharmaceutical industry, since it receives large sums from them to review their new drug applications.
  3. Note, too, that only two countries in the world permit these ads: the US and New Zealand.

I find it interesting that I can’t get a $0.10 pen from the drug companies any longer, but our patients can get billions of dollars in advertising given to them “free” without any concern about what this is costing our health care system.

presented by

Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist (doctor specializing in heart rhythm disorders) practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine. He entered the blog-o-sphere in November, 2005. He writes regularly at Dr. Wes. DISCLAIMER: The opinions expressed in this blog are strictly the those of the author(s) and should not be construed as the opinion(s) or policy(ies) of NorthShore University HealthSystem, nor recommendations for your care or anyone else's. Please seek professional guidance instead.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.